Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […]
» Read more